[HTML][HTML] Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome?

TC Theoharides - Molecular Neurobiology, 2022 - Springer
SARS-CoV-2 infects cells via its spike protein binding to its surface receptor on target cells
and results in acute symptoms involving especially the lungs known as COVID-19. However …

[HTML][HTML] The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as …

H Zalpoor, A Akbari, A Samei… - Cellular & Molecular …, 2022 - Springer
The novel coronavirus disease 2019 (COVID-19) pandemic has spread worldwide, and
finding a safe therapeutic strategy and effective vaccine is critical to overcoming severe …

[HTML][HTML] Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study

G Cecchetti, F Agosta, E Canu, S Basaia, A Barbieri… - Journal of …, 2022 - Springer
Background and objectives To explore cognitive, EEG, and MRI features in COVID-19
survivors up to 10 months after hospital discharge. Methods Adult patients with a recent …

[HTML][HTML] The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms

F Chen, Y Chen, Y Wang, Q Ke, L Cui - Translational neurodegeneration, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …

[HTML][HTML] Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic

S Dewanjee, J Vallamkondu, RS Kalra… - Molecular …, 2021 - Springer
The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …

[HTML][HTML] Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms

P Huang, LY Zhang, YY Tan, SD Chen - Translational Neurodegeneration, 2023 - Springer
The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …

[HTML][HTML] Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter …

AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …

ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations

VS Hernández, MA Zetter, EC Guerra… - Experimental …, 2021 - Elsevier
We examined cell type-specific expression and distribution of rat brain angiotensin-
converting enzyme 2 (ACE2), the receptor for SARS-CoV-2, in the rodent brain. ACE2 is …

[HTML][HTML] The impact of COVID-19 on comorbidities: a review of recent updates for combating it

JA Malik, S Ahmed, M Shinde, MHS Almermesh… - Saudi Journal of …, 2022 - Elsevier
Coronavirus disease is caused by the SARS-CoV-2 virus. The virus first appeared in Wuhan
(China) in December 2019 and has spread globally. Till now, it affected 269 million people …

[HTML][HTML] Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care

S Toniolo, M Scarioni, F Di Lorenzo… - Journal of …, 2021 - content.iospress.com
Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as
an acute and possibly also long-term sequela of the disease. Direct viral entry as well as …